News
AstraZeneca signs $4.7bn obesity drugs deal with China's CSPC
CSPC will receive an upfront payment of $1.2 billion and could earn up to $3.5 billion more from development and regulatory milestones
Jan 30, 2026
This Site is Intended for Healthcare Professionals Only